Angiotensin II increased neuronal stem cell proliferation: role of AT2R.

Angiotensin II (Ang II), known a potent vasoactive substance in the renin-angiotensin system in the brain, plays a critical role in systemic blood pressure control. However, increasing evidence indicated that the physiological role of Ang II go beyond its vasoactive effect. In the present study, we demonstrated that Ang II type-1 receptor (AT1R) and type-2 receptor (AT2R) were expressed in primary rat hippocampal neuronal stem cells (NSCs). Treatment of rat hippocampal NSCs with Ang II increased cell proliferation. Pretreatment of NSCs with specific AT2R, but not AT1R, antagonist significantly suppressed Ang II-induced cell proliferation. Furthermore, Ang II stimulated ERK and Akt phosphorylation in NSCs. Pretreatment of MEK inhibitor, but not PI3K inhibitor, inhibited Ang II-induced ERK phosphorylation as well as cell proliferation. In addition, stimulation of NSCs with Ang II decreased expression of KV 1.2/KV 3.1 channels and blocked K(+) currents which lie downstream of ERK activation. Taken together, these findings underpin the role of AT2R as a novel target that regulates cell proliferation mediated by Ang II with implications for therapeutic intervention for regulation of neurogenesis.

Introduction

It is well known that Angiotensin II (Ang II) is the principal vasoactive substance of the renin-angiotensin-system (RAS) with a variety of physiological actions, including vasoconstriction, aldosterone release, and cell growth [1], [2]. Moreover, increasing evidence highlighted that brain Ang II plays an important role in mediating diverse function such as neuronal injury, neuroinflammation and cognitive function via a brain-specific RAS [3], [4], [5], [6]. Ang II exerts its biological effect via binding two major receptors, the Ang II type-1 receptor (AT1R) and type-2 receptor (AT2R). Although previous study reported that AT2R is predominantly expressed in the fetus and its densities decline rapidly after birth [7], our recent findings demonstrated that in both rats and mice, AT2R expression in the brain is lower in fetus and neonate than that in adults, and that AT1R exhibits an opposite expression profile [8], suggesting an involvement of a potentially important functional role for AT1R and AT2R in brain developmental processes such as neurogenesis.

It is now well-known that neurogenesis is persistent in mammalian brain until adult [9], which is critical for specific cognitive functions, such as learning & memory [10], [11]. Active neurogenesis occurs throughout life and relies upon the proliferation, migration and proper differentiation of NSCs and is regulated by a variety of physiological and pathological stimuli [12], [13], [14]. Despite significant progress has been made in NSC proliferation, the role of Ang II in rat hippocampus NSC proliferation has never been investigated.

Ang II has been clearly demonstrated to induce cell proliferation [15], [16]. It has been postulated that the AT1R and AT2R have opposing actions on proliferation, although this issue remains controversial. Majority of Ang II-mediated cell proliferation has been attributed to AT1R as evidenced that many studies have more precisely investigated the role of AT1R in cell proliferation [15], [16], [17]. On the other hand, accumulating evidence indicated that activation of AT2R promoted neuronal differentiation [18], [19], [20] and neurite outgrowth [21], [22]. Controversially, despite previous study demonstrated that stimulation of AT2R inhibited cell proliferation in PC12W cells [18], other studies have suggested an association of AT2R with cell proliferation [23], [24], [25]. Whether the effect of Ang II on NSC proliferation is mediated by the AT1R or the AT2R remains unknown.

It has been demonstrated that voltage-gated potassium channels (KV) affect cell mitogenesis, which was initially reported in human T lymphocytes [26]. Recent studies suggest that KV play an important role in controlling proliferation in numerous types of cell, including glial cells, lymphocyte, endothelial cells, bereast and prostate cancer cells, and stem cell [27], [28], [29], [30], [31]. Several types of K+ current have been found in NSCs, such as IKDR (encoded by KV 1.2, KV 1.5 and KV 1.6), IA (encoded by KV 1.4), TEA-sensitive IKDR (encoded by KV 3.1) [32], [33], [34], in which, blockage of KV 1.3 and KV 3.1 channels has been reported to increase NSC proliferation [35]. Interestingly, Ang II has been shown to regulate both K+ current and K+ channel expression in different types of cell, including rostral ventrolateral medulla neurons [36], mesenchymal stem cells [37]. For instance, Ang II via AT1R increases neuronal firing rate and reduces KV and A-type K+ currents [38], [39]. AT2R also can modulate K+ currents in cultured neurons [40] and ventricular myocytes [41]. However, it remains to be clarified whether KV channels modulate Ang II-mediated proliferation in NSCs and, if so, AT1R or AT2R is involved in regulation of K+ currents.

In the current study, we have investigated the effect of Ang II, which is the terminal effector arm of RAS, on NSC proliferation. We show direct evidence that Ang II/AT2R axis in NSCs may contribute to the NSC proliferation via a previously unidentified role of AT2R. Moreover, we have also demonstrated that the enhancement of Ang II in the process of NSC proliferation is mainly mediated by ERK signaling with downstream blockage of K+ channel.

Materials and Methods

Reagents

Ang II, PD123319, losartan, CGP42112A, tetraethylammonium chloride (TEA), α-Dendrotoxin (α-DTX), 4-Aminopyridine (4-AP) and tetrodotoxin (TTX) were purchased from Sigma Chemicals (St. Louis, MO). The specific MEK1/2 inhibitor U0126 and PI3K inhibitor LY294002 was purchased from Calbiochem (San Diego, CA).

Animals

Pregnant female Sprague Dawley rats were purchased from Charles River Laboratories, Inc. (Wilmington, MA). All of animals were housed under conditions of constant temperature and humidity on a 12-h light, 12-h dark cycle, with lights on at 0700 h. Food and water were available ad libitum. All animal procedures were performed according to the protocols approved by the Institutional Animal Care and Use Committee of the University of Nebraska Medical Center.

Isolation, Differentiation & Characterization of NSCs

NSCs derived from the hippocampus of embryonic day18 (E18) fetus were cultured in substrate-free tissue culture T75 flasks as reported by Tian et al [42]. After 4–7 days, NSCs formed neurospheres and were dissociated with Trypsin-EDTA for 20 min at 37°C and plated on poly-D-lysine pre-coated plates (density: 1×105 cells/well for 24-well plate, 1×104 cells/well for 96-well plate) and were used if found more than 90% nestin+ (a marker for progenitor cells).

Western Blotting

NSCs were lysed using the Mammalian Cell Lysis kit (Sigma, St. Louis, MO). Cell lysis containing 20 µg of protein were subjected to electrophoresis on a 12% sodium dodecyl sulfate-ployacrylaminde (SDS) gel and blotted onto a polyvinylidene difluoride membrane with a semi-dry blotting apparatus. After blocking, membranes were then probed with antibodies recognizing the AT1R (1∶250, Santa Cruz), AT2R (1∶250, Abcam), p-ERK (1∶500, Cell Signaling, Danvers), p-Akt (1∶500, Cell Signaling, Danvers) and β-actin (1∶5000, Santa Cruz). Secondary antibodies were alkaline phosphatase conjugated to goat anti mouse/rabbit IgG (1∶5000). Signals were detected by chemiluminescence (Pierce, Rockford, IL). All of the Western blot experiments were repeated three times individually and representative blots are presented in the figures.

Immunocytochemistry

Dissociated NSCs were plated on the coverslip. The cells at different time were fixed with 4% paraformaldehyde for 20 minutes at room temperature according to the experiment protocol. The cells were permeabilized and blocked with solution containing 10% normal goat serum (NGS), 0.3%Triton X-100 in PBS at room temperature for 2 hours. Next, the cells were incubated with primary antibody (mouse anti-Nestin: 1∶250, Millipore; goat anti-AT1R: 1∶250, Santa Cruz; rabbit anti-AT2R, 1∶250, Abcam) in 10% NGS, 0.3%Triton X-100 in PBS at 4°C overnight. Following 3 washes with PBS, the cells were exposed to secondary fluorescence antibody for 2 hr. After washing with PBS for 3 times, the cells were mounted on the slide with anti-fade reagent with DAPI at room temperature. The slides were examined with a laser confocal microscope (Leica TSC STED).

Quantitative Real-Time PCR

RNA was extracted using TRIZOL Reagent (Invitrogen, NY) according to the manufacturer’s instructions. The RNA quality and quantity was verified using NanoDrop 2000 (Thermo, MI). Total RNA was reverse-transcribed using the iScript cDNA synthesis kits (Bio-RAD, CA) according to manufacturer’s protocols. Quantitative RT-PCR assays were carried out using SsoFast Eva Green Supermix RT-PCR kit (Bio-RAD, CA). Relative quantification was analyzed using PTC-200 (Bio-RAD, CA) and Chromo 4 continuous fluorescence detector (Bio-RAD, CA). In each experiment, GAPDH RNA was amplified as a reference standard. Expression data for different KV channel after Ang II treatment was first normalized against GAPDH RNA as ΔCT, and then the relative expression was compared to untreated group using the ΔΔCT method for quantification in Opticon Monitor software (Bio-RAD, CA). Relative fold changes were determined as RQ values. The primers were designed using online software at https://www.genscript.com/ssl-bin/app/primer and synthesized in the Eppley Cancer Institute Molecular Biology Core Laboratory on the campus of the University of Nebraska Medical Center.

Whole Cell Patch-clamp to Measure Potassium Current

The whole cell patch-clamp technique was used to determine the effect of Ang II on K+ currents in NSCs. This experiment was carried out using an Axopatch 200 A amplifier (Axon Instruments, Foster City, CA). Measurements of the K+ current were performed in episodic-stimulation mode. For the K+ current measurement, patch pipettes were filled with (in mM) 135 KCl, 5 EGTA, 10 HEPES, 2 MgCl2, 0.25 CaCl2, 1 ATP, 0.1 GTP and 15 glucose, pH 7.2. The extracellular solution consisted of the following composition (in mM): 134 NaCl, 5.4 KCl, 2 MgCl2, 10 HEPES, 10 glucose, 1.35 CaCl2, 0.3 NaH2PO4 and 0.3 CdCl2, pH 7.4. Na+ channels were blocked by TTX (3 µM). Cell membrane capacitance was determined by integrating the capacitive current evoked by a voltage step from 0 to 5 mV and dividing the resulting charge by the voltage step. Currents were not leak subtracted. Current traces were sampled at 10 kHz and filtered at 5 kHz. Holding potential was −80 mV. Current-voltage relations were elicited by test potentials over the range of −80 mV to +80 mV, with duration of 400 ms in 20 mV increments (5 s between steps). Peak currents were measured for each test potential.

Cell Proliferation Assay

Cell proliferation was measured by CyQUANT® NF Cell Proliferation Assay Kit (Invitrogen, NY). Briefly, NSCs dissociated from neurosphere were seeded in 96-well plates at a density of 104 cells/well for 2 days and were pre-treated with AT1R antagonist-Losartan, AT2R antagonists-PD123319, MEK inhibitor-U0126 or PI3K inhibitor-LY294002 for 1 hr followed by subsequent treatment with Ang II for 48 hrs. Then, 200 µl of the CyQUANT® GR dye/cell-lysis buffer was added into each well and incubated in the CO2 incubator for 15 min. Without washing, fluorescence intensity of each well was obtained using a Dynatech MR5000 plate counter at excitation and emission wavelengths of 480 and 520 nm, respectively.

Viral Transduction in NSCs

NSCs dissociated from neurosphere were seeded in 24-well plates at a density of 105 cells/well. At this time, Ad5-SYN-AT2R-IRES-EGFP or Ad5-SYN-EGFP were added to the culture medium (5×107 infectious units per well), three days later followed by monitoring for AT2R expression using western-blot analyses based upon previous report [43], and performed the cell proliferation experiments.

Statistical Analysis

Data were expressed as mean ± SEM. Significance of differences between control and samples treated with various drugs was determined by one-way ANOVA followed by post hoc least significant difference (LSD) test. Values of P<0.05 were considered as statistically significant.

Results

Ang II Increased Cell Proliferation of NSCs through AT2R

To assess the effects of Ang II on the cell proliferation of NSCs, rat NSCs were exposed to varying concentrations of Ang II for 48 h and cell proliferation assessed by CyQuant assay. As shown in Figure 1A, Ang II induced NSC proliferation in a concentration-dependent manner. Increasing concentrations of Ang II (0.01, 0.1, 1, 10, 100 µmol/L) resulted in increased cell proliferation by 12%, 35%, 54%, 36% and 43%, respectively. We next assessed whether the effect of Ang II was mediated via its binding to its cognate receptor AT1R and AT2R. As shown in Figure 1B, AT2R selective antagonist-PD123319, but not AT1R selective antagonist-losartan, blocked cell proliferation induced by Ang II in rat NSC culture. To further consolidate these observations, we treated NSCs with AT2R agonist-CGP42112A and found that CGP42112A increased cell proliferation, indicating that the effect of Ang II on cell proliferation is mainly through AT2R pathway (Figure 1C). Moreover, as shown in Figure 1D, NSCs with overexpression of AT2R showed higher response in proliferation than that of control group, further confirming AT2R is critical for Ang II-mediated cell proliferation.

Figure 1

Effect of Ang II on NSC proliferation.

A) Ang II (0.01, 0.1, 1, 10 and 100 µM) increased NSC proliferation in a concentration-dependent manner. NSCs were treated with different concentrations of Ang II for 48 hours followed by CyQUANT assay. B) The blockade of AT1R and AT2R on NSCs proliferation. Cells were pretreated with specific antagonist to AT1R or AT2R for 1 hour followed by treatment with Ang II for another 48 hours. Cell proliferation was assessed by CyQUANT assay. C) CGP42112A (10, 100 and 1000 nM) induced increase of NSC proliferation in a concentration-dependent manner. NSCs were treated with different concentrations of CGP42112A for 48 hours followed by CyQuant assay. D) Effect of AT2R overexpression on NSC proliferation. AT2R expression in NSCs transduced with control virus and AT2R virus for 72 hours as shown in the inset. *P<0.05 vs control, #P<0.05 vs Ang II-treated group, n = 5 in each group.

Expression Pattern of AT1R and AT2R in NSCs

Since Ang II mediates signaling via binding to its cognate receptor, AT1R and AT2R, we next examined the expression pattern of AT1R and AT2R in rat NSCs. Interestingly, we observed increased expression of both AT1R (Figure 2A) and AT2R (Figure 2B) in cultures from days 0 to day 3 by immunocytochemistry. These findings were further confirmed by Western-blot analysis (Figure 2C).

Figure 2

Expression pattern of AT1R and AT2R in NSCs.

A) Representative immunofluorescence images showing the AT1R expression in NSCs. 0D: 0 day; 3D: 3 days. NSCs cultured at day 0 or day 3 were fixed with 4% paraformaldehyde followed by immunostaining for nestin (red), a neural stem cell marker, and AT1R (green). DAPI (blue): nuclei marker. Scale bar:40 µm. B) Representative immunofluorescence images showing the AT2R expression in NSCs. NSCs cultured at day 0 or day 3 were fixed with 4% paraformaldehyde followed by immunostaining for nestin (red) and AT2R (green). DAPI (blue): nuclei marker. Scale bar:40 µm. C) Representative blots (left panel) and mean data of relative blot density (right panel) showing expression pattern of AT1R and AT2R in NSCs. Expression of AT1R or AT2R was determined from NSCs cultured for 0 hour, 12 hours, 1 day, 2 days, 3 days and 4 days by Western Blot analysis. *P<0.05 vs AT1R expression in NSCs cultured at 0 hour; #P<0.05 vs AT2R expression in NSCs cultured at 0 hour, n = 3 in each group.

Ang II-induced ERK and Akt Activation in NSCs

ERK/mitogen-activated protein kinase (MAPK) and PI3K/Akt pathway has been demonstrated to play a crucial role in cell proliferation [44], [45]. It was therefore of interest to examine the effect of Ang II on ERK and Akt regulation in rat NSCs. According to the results showing in Figure 2, we cultured NSCs for 4 days, and then performed the experiments. As shown in Figure 3A, exposure of NSCs to Ang II resulted in a sustained and time-dependent activation of ERK and Akt. However, only ERK, but not Akt, was blocked by pretreatment of cells with the AT2R antagonist-PD123319 for 1 hour, which significantly attenuated Ang II-mediated sustained activation of ERK (Fig. 3B). Consistent with the role of AT2R in NSC proliferation, AT2R agonist-CGP42112A exhibited the similar effect as Ang II, as shown in Figure 3C. Since MEK1/2 lies upstream of ERK, pretreatment of cells with MEK inhibitor U0126 resulted in abrogation of ERK phosphorylation induced by Ang II. So the functional role of Ang II-induced ERK activation in mediating NSC proliferation was corroborated using cell viability assay, wherein Ang II failed to exert its proliferation effect in cells pre-treated with MEK inhibitor-U0126, but not PI3K inhibitor-LY294002, thereby underscoring the role of this pathway in Ang II-mediated NSC proliferation (Fig. 3D).

Figure 3

Ang II -induced ERK and Akt activation.

A) Representative blots (upper panel) and mean data of relative blot density (lower panel) showing Ang II induced a rapid phosphorylation of ERK and Akt in NSCs. Cells were treated with Ang II for different time followed by western- blot analysis. *P<0.05 vs untreated group; n = 3 in each group. B) Representative blots (upper panel) and mean data of blot density (lower panel) showing blockade of AT1R and AT2R on phosphorylation of ERK and Akt. NSCs were pre-treated with specific antagonist to AT1R or AT2R for 1 hour followed by incubation with Ang II for 30 min. *P<0.05 vs untreated group, #P<0.05 vs Ang II-treated group; n = 3 in each group. C) Representative blots (upper panel) and mean data of relative blot density (lower panel) showing CGP42112A induced a rapid phosphorylation of ERK and Akt in NSCs. Cells were treated with CGP42112A for different time followed by western-blot analysis. *P<0.05 vs untreated group; n = 3 in each group. D) Effect of blockade of ERK and Akt on Ang II-induced NSC proliferation. Cells were pretreated with specific ERK or Akt pathway inhibitor-U0126 or LY2940002 for 1 hour followed by treatment with Ang II for another 48 hours. Cell proliferation was assessed by CyQUANT Assay. *P<0.05 vs untreated group, #P<0.05 vs Ang II- treated group; n = 5 in each group.

Ang II Decreased the Expression of K+ Channel in NSCs

Since cell proliferation can be regulated by modulation of K+ channel activity, Ang II has been shown to regulate both K+ current and K+ channel expression in different types of cell [36], [37]. It was reasonable to examine the effect of Ang II on K+ channel expression and K+ current in NSCs. As shown in Figure 4A, treatment of NSCs with Ang II (0.1 µM) for 24 hours specifically decreased mRNA level of tested K+ channel, in which KV1.2 and KV 3.1 decreased more than 10 fold. Functional implication of K+ channel in NSC proliferation induced by Ang II was further corroborated using proliferation assays, wherein 4-AP (0.01, 0.1 and 1 mM), a specific KV channel blocker, increased NSC proliferation in a concentration-dependent manner (Fig. 4B). These findings were further confirmed by KV1.2 and KV 3.1 specific blocker, α-DTX and low dosage of TEA (0.1 mM) respectively, as shown in Figure 4C and 4D. These findings underpinned the critical role of K+ channel in regulation of NSC proliferation.

Figure 4

Ang II decreased the expression of Kv channel in NSCs.

A) Effect of Ang II on the expression of different KV channels by real-time RT-PCR assay. NSCs were treated with Ang II (0.1 µM) for 24 hours followed by RT-PCR. n = 3 in each group. B) KV channel blockade with 4-AP induced NSC proliferation in concentration-dependent manner. NSCs were treated with different concentrations of 4-AP for 48 hours followed by CyQUANT assay. C) Effect of TEA on NSCs proliferation. NSCs were treated with different concentrations of TEA for 48 hours followed by CyQUANT assay. D) α-DTX induced NSC proliferation in concentration-dependent manner. NSCs were treated with different concentrations of α-DTX for 48 hours followed by CyQUANT assay. *P<0.05 vs untreated control group, n = 5 in each group.

Ang II-mediated Blockage of K+ Currents Lies Downstream of AT2R/ERK Pathway

Based on the premise that KV channels mediate cell proliferation and that Ang II regulated K+ currents in other cell system, it was rationalized that K+ currents through AT2R is a pre-requisite for increased NSC proliferation mediated by Ang II. NSCs were treated with Ang II and CGP42112A for 48 hours, then subsequently assessed for K+ currents using whole-cell patch clamp. As shown in Figure 5A–C, Ang II and CGP42112A significantly decreased K+ currents in NSCs. The effect of Ang II on K+ currents was restored by pretreatment of PD123319, but not by losartan. These findings underpinned the role of AT2R in Ang II-mediated blockage of K+ currents. To further unravel the role of ERK pathway in Ang II-mediated blockage of K+ currents, NSCs were pretreated with the MEK inhibitor-U0126 and assessed for K+ currents. As shown in Figure 5A–C, pre-treatment of cells with U0126 markedly attenuated Ang II-induced blockage of K+ currents.

Figure 5

Ang II-mediated blockage of K+ currents lies downstream of AT2R/ERK pathway.

A) Representative K+ current traces showing response of Ang II, Ang II+ PD123319, Ang II+Losartan, CGP42112A or Ang II+U0126 in NSCs evoked from −80 to 80 mV. NSCs were pre-treated with vehicle, Losartan, PD123319, or U0126 for 1 hour followed by incubation with Ang II or CGP42112A for 24 hours. B) Mean data of peak K+ current change from −80 to 80 mV. C) Peak K+ current change at +80 mV. *P<0.05 vs untreated control group, #P<0.05 vs Ang II- treated group; n = 10 in each group.

Discussion

It is well-recognized that new dentate granule cells are continuously generated from NSCs and are integrated into the existing hippocampal circuitry in the adult mammalian brain through an orchestrated process termed adult neurogenesis [46]. Neurogenesis is regulated by a variety of physiological as well as pathological stimuli [12], [13], [14]. This study illuminates a novel prospective on the involvement of Ang II in regulation of NSC proliferation. Studies to determine whether Ang II treatment enhances the differentiation of NSCs into neurons or astrocytes are under investigation.

It is well-known that the cardiovascular and other actions of Ang II are mediated by AT1R and AT2R, which are seven transmembrane glycoproteins with 30% sequence similarity [2], [47], [48], [49], [50], [51], [52]. Mounting evidence have demonstrated that the functional local RAS have been found in such diverse organ system as the pancreas, heart, kidney as well as the nervous system [47], [48], [50], [51], [53]. Of note, in our NSC cell culture system, there is a time-dependent increase of AT1R and AT2R expression. Therefore, we speculate that RAS may be involved in NSC proliferation. As we expected, pretreatment of NSCs with AT2R antagonist inhibited Ang II-induced NSC proliferation. However, this finding was not consistent with the previous reports that AT1R activation enhanced the proliferation of somatic cells, such as smooth muscle cells and lung fibroblasts [16], [17], and DNA synthesis in mouse embryonic stem cells [54]. Thus, it is possible that distinct mechanisms underlie the effects of Ang II on proliferation of different types of stem cells. While the role of AT1R in NSC proliferation awaits for further investigation, the importance of the Ang II-AT2R axis in the maintenance of normal endocrine development has been suggested recently [55], which adds credence to our present findings.

In this study, we observed that Ang II induced ERK and Akt phosphorylation. These signaling pathways have been shown to regulate NSC proliferation [44], [45]. Interestingly, blocking AT2R resulted in suppression of Ang II-induced ERK activation, but not AT1R. The findings reported here on Ang II-mediated activation of ERK pathway are consistent with several lines of published reports [43], [56]. Consistent with the previous studies [22], [57], data presented here provide strong evidence that stimulation of AT2R induced activation of ERK/MAPK pathway.

Another interesting finding herein was the observation that inhibition of PI3K/Akt failed to reverse Ang II-mediated NSC proliferation thereby ruling out the potential role of this pathway. It is well known that activation of PI3K/Akt and its downstream pathway-NF-κB plays a key role in enhancing NSC proliferation following exposure to a wide array of stimuli [58], [59]. Our results are not consistent with previous reports that PI3K/Akt transduces intracellular signals that regulate adult NSC proliferation [60]. Interestingly, all of those studies use the NSCs from adult rats, in which, the expression of AT1R and AT2R pattern is total different from NSCs from fetal or neonate rats [8]. Thus, the different findings of involvement of PI3K/Akt in NSCs from adult and neonate animal indicate that Ang II and its receptor may play an important role in regulation of NSC proliferation.

Another novel finding of this study is the role of K+ channel in Ang II-mediated increased proliferation, thereby lending credence to previous reports indicating the involvement of K+ channels and K+ currents in cell proliferation [37]. Previous reports demonstrated the co-localization of K+ channel with the neural progenitor cells isolated from subventricular zone [61]. In our cell culture system, different subtypes of KV channels were expressed in NSCs. Ang II is known to exert its action by regulation of K+ currents in neuronal cell system [62]. However, whether Ang II can regulate K+ currents in NSCs remains less clear. Herein we report that Ang II induced inhibition of K+ currents through activation of AT2R. Both AT1R and AT2R belong to the large family of G protein-coupled receptors with seven transmembrane domains [49], [50], [51], [52]. It is well established the mammalian K+ channels can be activated by G-protein-coupled receptors [63], [64]. Traditionally, Ang II was thought to inhibit K+ current via the activation of AT1R [38], [65] and stimulates K+ current via AT2R [40]. However, previous study also demonstrated the inhibition effect of Ang II on K+ current through AT2R [66]. Our findings provide another example of Ang II inhibit K+ currents via AT2R, but not AT1R. A key finding here is that Ang II-induced inhibition of K+ currents via ERK activation. It was evident from our findings that Ang II-mediated inhibition of K+ currents is ERK-dependent activation, and ensuing NSC proliferation. To further address the relevance of KV channel in NSC proliferation, we test the effect of pan KV channel blocker and specific KV 1.2/KV 3.1 blocker in NSC proliferation. 4-AP, α-DTX and low dosage of TEA significantly increased NSC proliferation, while high dosage of TEA inhibited NSC proliferation. It is reported that high concentration of TEA induced mammalian neuroblastoma cell swelling and decreased cell proliferation [67]. Whether same mechanism also involved in our system needs to be further investigated. Nevertheless, our findings are in agreement with the previous reports describing the involvement of KV channel in NSC proliferation [35].

In summary, activation of the AngII/AT2R axis resulted in stimulation of ERK pathways leading to inhibition of KV channels, which in turn, resulted in increased NSC proliferation. Taken together, our findings suggest that although the two pathways were upregulated by Ang II, only ERK was involved in Ang II-mediated increased proliferation of NSCs. A better understanding of these molecular pathways could be critical for the understanding how Ang II play important role in the NSC proliferation in the central nervous system.